<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC4195804/results/search/disease/results.xml">
  <result pre="the development of coronavirus specific therapeutics. However, the emergence of" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), and more recently, Middle East respiratory syndrome"/>
  <result pre="(MERS-CoV), was isolated as the causative agent of a severe" exact="pneumonia" post="in several patients in the Middle East [1]. Globally,"/>
  <result pre="of America (http://www.who.int/csr/don/2014_05_16_mers/en/, http://www.cdc.gov/coronavirus/mers/). This CoV is closely related to" exact="severe acute respiratory syndrome" post="CoV (SARS-CoV), an epidemic that was short-lived but alarming"/>
  <result pre="fevers, indications similar to influenza, but later progresses to atypical" exact="pneumonia" post="in most cases [16]. Although, many antiviral agents have"/>
  <result pre="effect was specific for SARS-CoV replication because no effect on" exact="influenza" post="virus replication was observed with up to 50 μM"/>
  <result pre="a broad-spectrum activity against other coronaviruses, including MERS-CoV and mouse" exact="hepatitis" post="virus (MHV) [47]. Entry inhibitors Viral entry is an"/>
  <result pre="used for the treatment of some viral infections, such as" exact="hepatitis" post="C virus, albeit with some adverse side effects including"/>
  <result pre="hepatitis C virus, albeit with some adverse side effects including" exact="hemolytic anemia," post="elevated transaminase levels and bradycardia [83], depression, suicide, relapse"/>
  <result pre="1ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN Engl J Med36720121814182023075143 2••RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PenarandaS.BankampB.MaherK.ChenM.H.Characterization of a"/>
  <result pre="Cell Biol13119953393497593163 7HonC.C.LamT.Y.ShiZ.L.DrummondA.J.YipC.W.ZengF.LamP.Y.LeungF.C.Evidence of the recombinant origin of a bat" exact="severe acute respiratory syndrome" post="(SARS)-like coronavirus and its implications on the direct ancestor"/>
  <result pre="BoheemenS.de GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.HaagmansB.L.GorbalenyaA.E.SnijderE.J.Genomic characterization of a newly discovered coronavirus associated with" exact="acute respiratory distress syndrome" post="in humansMBio20123 15ItheteN.L.StoffbergS.CormanV.M.CottontailV.M.RichardsL.R.SchoemanM.C.DrostenC.DrexlerJ.F.PreiserW.Close relative of human Middle East respiratory"/>
  <result pre="basis for design of anti-SARS drugsScience30020031763176712746549 21••YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.The crystal structures of" exact="severe acute respiratory syndrome" post="virus main protease and its complex with an inhibitorProc"/>
  <result pre="This is the first report on the crystal structures of" exact="severe acute respiratory syndrome" post="virus main protease at different pH and its complex"/>
  <result pre="complexes as SARS-CoV 3C-like protease inhibitorsFEBS Lett58120075454545817981158 28WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.HsuH.H.HuangH.C.WuD.BrikA.Small molecules targeting" exact="severe acute respiratory syndrome" post="human coronavirusProc Natl Acad Sci U S A1012004100121001715226499 29ShaoY.M.YangW.B.PengH.P.HsuM.F.TsaiK.C.KuoT.H.WangA.H.LiangP.H.LinC.H.YangA.S.Structure-based"/>
  <result pre="of highly potent SARS-CoV 3CL protease inhibitorsChembiochem820071654165717722121 30ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the" exact="severe acute respiratory syndrome" post="3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg Med Chem1320055240525215994085 31ShieJ.J.FangJ.M.KuoC.J.KuoT.H.LiangP.H.HuangH.J.YangW.B.LinC.H.ChenJ.L.WuY.T.Discovery"/>
  <result pre="estersBioorg Med Chem1320055240525215994085 31ShieJ.J.FangJ.M.KuoC.J.KuoT.H.LiangP.H.HuangH.J.YangW.B.LinC.H.ChenJ.L.WuY.T.Discovery of potent anilide inhibitors against the" exact="severe acute respiratory syndrome" post="3CL proteaseJ Med Chem4820054469447315974598 32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters as mechanism-based"/>
  <result pre="Med Chem4820054469447315974598 32WuC.Y.KingK.Y.KuoC.J.FangJ.M.WuY.T.HoM.Y.LiaoC.L.ShieJ.J.LiangP.H.WongC.H.Stable benzotriazole esters as mechanism-based inactivators of the" exact="severe acute respiratory syndrome" post="3CL proteaseChem Biol13200626126816638531 33TsaiK.C.ChenS.Y.LiangP.H.LuI.L.MahindrooN.HsiehH.P.ChaoY.S.LiuL.LiuD.LienW.Discovery of a novel family of"/>
  <result pre="inhibitors of SARS-CoV 3CL proteaseBioorg Med Chem Lett2020103569357220494577 37HarcourtB.H.JuknelieneD.KanjanahaluethaiA.BechillJ.SeversonK.M.SmithC.M.RotaP.A.BakerS.C.Identification of" exact="severe acute respiratory syndrome" post="coronavirus replicase products and characterization of papain-like protease activityJ"/>
  <result pre="characterization of papain-like protease activityJ Virol782004136001361215564471 38BarrettoN.JuknelieneD.RatiaK.ChenZ.MesecarA.D.BakerS.C.The papain-like protease of" exact="severe acute respiratory syndrome" post="coronavirus has deubiquitinating activityJ Virol792005151891519816306590 39FriemanM.BasuD.MatthewsK.TaylorJ.JonesG.PicklesR.BaricR.EngelD.A.Yeast based small molecule"/>
  <result pre="nuclei acid unwinding by SARS-CoV helicase. 42PaoliniC.De FrancescoR.GallinariP.Enzymatic properties of" exact="hepatitis" post="C virus NS3-associated helicaseJ Gen Virol8120001335134510769077 43KimM.K.YuM.S.ParkH.R.KimK.B.LeeC.ChoS.Y.KangJ.YoonH.KimD.E.ChooH.2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral"/>
  <result pre="NS3-associated helicaseJ Gen Virol8120001335134510769077 43KimM.K.YuM.S.ParkH.R.KimK.B.LeeC.ChoS.Y.KangJ.YoonH.KimD.E.ChooH.2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both" exact="hepatitis" post="C virus (HCV) and SARS-associated coronavirus (SCV)Eur J Med"/>
  <result pre="soluble receptorBiochem Biophys Res Commun31920041216122115194496 67••SimmonsG.GosaliaD.N.RennekampA.J.ReevesJ.D.DiamondS.L.BatesP.Inhibitors of cathepsin L prevent" exact="severe acute respiratory syndrome" post="coronavirus entryProc Natl Acad Sci U S A1022005118761188116081529 First"/>
  <result pre="domain within the SARS-CoV envelope. 70YangZ.Y.HuangY.GaneshL.LeungK.KongW.P.SchwartzO.SubbaraoK.Nabel GJ: pH-dependent entry of" exact="severe acute respiratory syndrome" post="coronavirus is mediated by the spike glycoprotein and enhanced"/>
  <result pre="Commun31220031159116414651994 73ShahP.P.WangT.KaletskyR.L.MyersM.C.PurvisJ.E.JingH.HurynD.M.GreenbaumD.C.SmithA.B.IIIBatesP.A small-molecule oxocarbazate inhibitor of human cathepsin L blocks" exact="severe acute respiratory syndrome" post="and ebola pseudotype virus infection into human embryonic kidney"/>
  <result pre="of viral entry and possible antiviral targets. 77••AdedejiA.O.SeversonW.JonssonC.SinghK.WeissS.R.SarafianosS.G.Novel inhibitors of" exact="severe acute respiratory syndrome" post="coronavirus entry that act by three distinct mechanismsJ Virol8720138017802823678171"/>
 </snippets>
</snippetsTree>
